Clinical Policy: Palopegteriparatide (Yorvipath)
As stated in the prescribing information, the prescriber should confirm 25-hydroxyvitamin D stores are within the normal range and serum calcium is above 7.8 mg/dL before starting Yorvipath.
HIGHLIGHTS OF PRESCRIBING INFORMATION These
The effectiveness and safety of YORVIPATH in adults with hypoparathyroidism were evaluated in a 26-week, randomized, double-blind, placebo-controlled, phase 3 study (Study 1
Your Treatment Journey and Support with ASAP | YORVIPATH
Your healthcare provider should check your blood calcium before you start and during your treatment with YORVIPATH. Tell your healthcare provider right away if you have nausea, vomiting, dizziness,
Yorvipath for Hypoparathyroidism
How Does Yorvipath Work to Treat Hypoparathyroidism? Normally, parathyroid hormone (PTH) slows down bone-building cells and speeds up bone-breaking cells, leading to bone
Yorvipath for hypoparathyroidism – Hypoparathyroidism News
Yorvipath, formerly TransCon PTH, is an approved daily injection treatment to manage blood calcium levels in adults with hypoparathyroidism.
Your Guide to Yorvipath for Hypoparathyroidism
Your health care provider will do a blood test to check the amount of calcium and vitamin D in your blood before you start Yorvipath. How Was Yorvipath Studied for Hypoparathyroidism?
Yorvipath: Dosage, side effects, price, uses, and more
Yorvipath (palopegteriparatide) is a prescription injection that treats hypoparathyroidism in adults, Learn about dosage, side effects, cost, uses, and more.
Yorvipath (Ascendis Pharma, Endocrinology, Inc.): FDA Package Insert
Ascendis Pharma, Endocrinology, Inc.: YORVIPATH is indicated for the treatment of hypoparathyroidism in adults. YORVIPATH is a parathyroid hormone analog (PTH(1-34)) indicated
Yorvipath: Uses, Dosage, Side Effects, Warnings
Uses Side effects Before taking Directions Dosage Interactions What is Yorvipath? Yorvipath (palopegteriparatide) is an injectable parathyroid hormone replacement therapy that can
Take Charge of Hypopara | YORVIPATH® (palopegteriparatide)
High levels of calcium in the blood (hypercalcemia). YORVIPATH can cause some people to have higher blood calcium levels than normal. Your healthcare provider should check your blood calcium
PDF version includes complete article with source references. Suitable for printing and offline reading.